What lab workup is recommended for a patient suspected of having rhabdomyolysis (muscle breakdown disease)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Workup for Rhabdomyolysis

The essential laboratory workup for suspected rhabdomyolysis should include serum creatine kinase (CK), plasma myoglobin, complete electrolyte panel (with particular attention to potassium), renal function tests, and urinalysis. 1, 2

Core Laboratory Tests

  • Serum creatine kinase (CK): The primary diagnostic marker with levels typically >1000 U/L or at least 5 times the upper limit of normal. CK levels should be monitored serially to track disease progression and response to treatment. 2, 3

  • Serum myoglobin: Important to measure as myoglobin is directly nephrotoxic and responsible for acute kidney injury in rhabdomyolysis. 1, 2

  • Complete electrolyte panel: Particularly important to monitor potassium, as hyperkalemia can lead to life-threatening cardiac arrhythmias. Also check calcium, phosphorus, and magnesium levels. 1, 4

  • Renal function tests: Serum creatinine and blood urea nitrogen (BUN) to assess for acute kidney injury, which occurs in 15-33% of rhabdomyolysis cases. 2, 3

  • Urinalysis: To check for myoglobinuria (which may appear as heme-positive with few or no red blood cells on microscopy). Note that urine myoglobin testing by dipstick/ultrafiltration may be positive in only 19% of cases. 2, 3

Additional Tests Based on Clinical Context

  • Liver function tests: To assess for hepatic involvement and distinguish between hepatocellular and other patterns of injury. 4

  • Creatine kinase isoenzymes: May help differentiate between cardiac and skeletal muscle injury. 1

  • Coagulation studies: To evaluate for disseminated intravascular coagulation, which can be a complication of severe rhabdomyolysis. 4

  • Arterial blood gas: To assess for metabolic acidosis, which commonly occurs in severe rhabdomyolysis. 4

Etiology-Specific Testing

  • Toxicology screen: For patients with suspected drug or toxin-induced rhabdomyolysis (responsible for up to 46% of cases). 3, 5

  • Viral studies: Consider testing for viral myositis if clinically indicated. 4

  • Autoimmune markers: Consider ANA, ASMA, ANCA if autoimmune myositis is suspected. 4

  • Compartment pressure measurement: If compartment syndrome is suspected based on clinical findings of pain, tension, paresthesia, or paresis in affected limbs. 1

Special Considerations

  • Repeat CK measurements: Serial monitoring is essential to track the course of muscle breakdown and guide fluid therapy. 1, 2

  • Note on false negatives: Rarely, rhabdomyolysis can present with normal CK levels, particularly if testing is delayed after the initial muscle injury. In these cases, urine or serum myoglobin may be more reliable. 6

  • Consider muscle biopsy: In cases of recurrent rhabdomyolysis, family history of muscle disorders, or when standard treatment fails to resolve symptoms, as approximately 10% of cases may be due to underlying myopathies. 3, 7

  • Cardiac assessment: Consider ECG and cardiac troponin in patients with severe rhabdomyolysis to rule out cardiac involvement. 4

Monitoring During Treatment

  • Fluid balance: Monitor input/output to ensure adequate hydration and urine output. 1, 2

  • Electrolytes: Check at least twice daily initially, with particular attention to potassium, calcium, and phosphorus. 1, 5

  • Renal function: Monitor creatinine and BUN at least daily to assess for development or progression of acute kidney injury. 2

  • Urine pH: Consider monitoring if alkalinization strategy is employed, though evidence for this approach is limited. 2

By following this comprehensive laboratory workup, clinicians can effectively diagnose rhabdomyolysis, identify its cause, monitor for complications, and guide appropriate treatment decisions.

References

Guideline

Rhabdomyolysis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Rhabdomyolysis.

Disease-a-month : DM, 2020

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Rhabdomyolysis with Rash Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Rhabdomyolysis-Associated Acute Kidney Injury With Normal Creatine Phosphokinase.

The American journal of the medical sciences, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.